result underscor hold rational stock challeng
medic segment well exposur competit med suppli busi
offset stabil improv core busi gener
issu seem cah-specif re-emerg steep industry-wid
deflat management appear overli optimist guidanc
assumpt factor
summari op incom beat ep miss guidanc cut due
cordi beat street rev vs pharma segment strength
vs off-set miss medic segment rev vs consolid
op incom street vs pharma segment beat
vs driven red oak moder gener deflat despit op incom
beat ep miss issu cordi ou drove tax rate ep guidanc
cut ep expect grow minim
due larg cordi
cordi med suppli drag ep power share management
conced issu face cordi segment take fix segment
profit re-emerg next year see nt catalyst revers pressur
earn power combin pressur face medic segment
issu glove rise competit make difficult share see posit
momentum come month
gener deflat exist drag ep guidanc appear self-
inflict management earn call prepar remark point gener deflat
reason guidanc cut along contract repric contribut steep sell-
disti howev answer analyst question
topic suggest guidanc cut relat gener price improv
gener deflat track seemingli overli optimist assumpt bake
guidanc view support management clarif throughout call emphas
gener price trend actual improv moder pace deflat y/i q/
 see chang competit environ
lower pt deriv appli pe/g ratio line stock
histor delta vs pe/g lt growth assumpt risk
overhang med suppli cordi
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
sell-sid gener deflat continu moder
move brand inflat remain high
patient recoveri busi continu remain on-track
management action result cordi return close
normal profit end
overhang medic suppli distribut
space also limit nt multipl expans
continu doubt suppos intent enter
pharmaci space amzn current oper
medic suppli distribut creat overhang
view also limit stock upsid
magnitud number brand drug price increas
sell-sid gener deflat continu moder
move brand inflat remain high
patient recoveri busi continu remain on-track
management action result cordi return close
normal profit end
capit deploy primarili focus capital-expenditure
tuck-in maintain dividend pay-out ratio
buyback like mute nt
discount pe/g pt
sell-sid gener deflat moder expect
abl continu leverag red oak yield
improv gener margin profit dollar
brand inflat begin increas low double-
digit number brand drug increas
cordi busi perform recov quicker
anticip patient recoveri acquisit synergi
greater expect
gener deflat acceler high-doubl digit
brand inflat continu moder mid-singl
digit manufactur choos increas price
acquisit synergi fail materi expect
delay
becom notabl competitor med
page
pleas see import disclosur inform page report
statement earn
page
pleas see import disclosur inform page report
